GlassScriptPhysician profile
Ann Jefferds
NPI 1386691558
$8,692.04
in general payments reported to CMS, 2019-2025
55 companies · $2,061 in 2025
The $2,061 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $304 · 2021: $483 · 2022: $1,361 · 2023: $1,850 · 2024: $2,181 · 2025: $2,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,092.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $797.58 | 2020-2025 | |
| Lilly USA, LLC | $729.29 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $684.66 | 2019-2025 | Otezla, Repatha, Evenity |
| Pfizer INC. | $684.23 | 2019-2025 | |
| Viiv Healthcare Company | $563.43 | 2022-2025 | Apretude |
| Boehringer Ingelheim Pharmaceuticals, INC. | $506.42 | 2019-2025 | Jardiance, Synjardy |
| Gilead Sciences, INC. | $459.70 | 2019-2025 | |
| Astellas Pharma US INC | $359.21 | 2019-2025 | Veozah |
| Glaxosmithkline, LLC. | $349.98 | 2020-2025 | Shingrix, Arexvy, Bexsero |
| Merck Sharp & Dohme LLC | $332.20 | 2020-2025 | Capvaxive, Gardasil 9, Vaxelis |
| Janssen Pharmaceuticals, INC | $298.84 | 2019-2025 | Spravato, Xarelto |
| Novo Nordisk INC | $291.11 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $279.05 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $193.44 | 2023-2025 | Rexulti |
| Corcept Therapeutics | $193.01 | 2024-2025 | Korlym |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $172.55 | 2019-2023 | |
| Idorsia Pharmaceuticals US INC | $172.53 | 2022-2025 | Quviviq, Quviviq |
| Astrazeneca Pharmaceuticals LP | $170.06 | 2019-2025 | Airsupra, Farxiga |
| Lucid Diagnostics INC. | $112.14 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $102.89 | 2020-2023 | |
| Nestle Healthcare Nutrition INC. | $91.91 | 2021-2022 | |
| Amarin Pharma, INC. | $81.52 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $80.95 | 2020-2021 | |
| Hologic Sales and Service, LLC | $74.62 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Axsome Therapeutics, INC. | $73.37 | 2023-2025 | Auvelity, Sunosi |
| Boston Scientific Corporation | $71.83 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $66.92 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $56.66 | 2025 | Voquezna |
| Xeris Pharmaceuticals, INC. | $50.53 | 2023-2024 | Gvoke Hypopen |
| Medtronic, INC. | $45.91 | 2025 | Inceptiv, Minimed 780g |
| Edwards Lifesciences Corporation | $44.71 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Neuronetics, INC. | $43.98 | 2025 | Neurostar Tms Therapy System |
| Sanofi Pasteur INC. | $42.93 | 2023-2024 | |
| Ultragenyx Pharmaceutical INC. | $42.66 | 2021-2022 | |
| Inspire Medical Systems, INC. | $40.55 | 2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $26.85 | 2020-2022 | |
| Quidel Corporation | $23.28 | 2022 | |
| Exeltis, USA INC. | $21.18 | 2024 | Slynd |
| Avanir Pharmaceuticals, INC. | $19.55 | 2019 | |
| Dexcom, INC. | $19.31 | 2025 | Dexcom G6 Transmitter |
| Pulmonx Corporation | $18.84 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Kowa Pharmaceuticals America, INC. | $17.98 | 2022 | |
| Dynavax Technologies Corporation | $17.29 | 2023 | Heplisav-B |
| Nevro Corp. | $17.04 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.28 | 2025 | Xifaxan |
| Tris Pharma INC | $15.33 | 2023 | Dyanavel Xr |
| Organon LLC | $14.71 | 2024 | |
| Supernus Pharmaceuticals, INC. | $14.41 | 2021 | |
| Verity Pharmaceuticals INC. | $13.95 | 2025 | Tlando |
| Neurocrine Biosciences, INC. | $13.94 | 2024 | Ingrezza |
| Exact Sciences Corporation | $13.10 | 2023 | Cologuard Collection Kit |
| Si-Bone, INC. | $12.44 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.09 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.66 | 2022 | |
| Eisai INC. | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Jefferds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.